Product Manual

REFERENCES/BIBLIOGRAFÍA
1. Unidentified curved bacilli on gastric epitheliums in active chronic gastritis. Lancet
1
:1273(1983).
2. Morris, A. J., et al., Long term follow-up of voluntary ingestion of Helicobacter pylori.
Ann. Intern. Med. 114:662(1991).
3. Marshall BJ and Warren JR. Unidentified curved bacilli in the stomach of patients
w
ith gastritis and peptic ulceration. Lancet 1:1311(1984).
4. Dooley CP, et al. Prevalence of Helicobacter pylori infection and histologic gastritis
in asymptomatic persons. N. Engl. J. Med. 321:1652(1989).
5
. Buck GE, et al. Relation of Campylobacter pyloridis to gastritis a and peptic ulcer.
J. Infect. Dis. 153:664(1986).
6. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflamma-
tion. J. Infect. Dis. 161:626(1990).
7
. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterol.
96(Suppl.2): 615(1989).
8. Blaser MJ. Pathogenesis of Helicobacter pylori-induced gastroduodenal diseases. In
new antibacterial strategies, Neu, HC (ed.). London: Churchill Livingston, pp.
1
43-153(1990).
9. Siurala M, et. al. Chronic gastritis: Dynamic and clinical aspects. Scan. J.
Gastroenterol. Suppl. 109:69(1985).
1
0. Sitas F, et al. Helicobacter pylori infection rates in relation to age and social class in
a population of Welsh men. Gut 32:25(1991).
11. Parsonnet J, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N.
Eng. J. Med. 325:1127(1991).
12. Nomura A, et al. Helicobacter pylori infection and gastric carcinoma among
Japanese Americans in Hawaii. N. Eng. J. Med. 325:1132(1991).
13. Musgrove C, et al. Campylobacter pylori: Clinical, histological and serological
studies. J. Clin. Pathol. 41:1316(1988).
14. Booth L, et al. Clinical importance of Campylobacter pyloridis and associated
serum IgG and IgA anti-body response in patients undergoing upper gastrointesti-
nal endoscopy. J. Clin. Pathol. 39:215(1986).
15. Fox JG, et al. Campylobacter pylori-associated gastritis and immune response in a
population at increased risk of gastric carcinoma. Am J. Gastroenterol. 84:775(1989).
16. Loffeld RJLF, et al. The prevalence of anti-Helicobacter (Campylobacter) pylori
antibodies in patients and healthy blood donors. J. Med. Microbiol. 32:105(1990).
17. Martin DF, et al. Campylobacter pylori, NSAIDS, and smoking: Risk factors for peptic
ulcer disease. Am. J. Gastroenterol. 84:1268(1989).
18. Perez-Perez GL, et al. Campylobacter pylori antibodies in humans. Ann. Intern.
Med. 109:11(1988).
ASSISTANCE/ASISTENCIA
For assistance, call Sekisui Diagnostics Technical Assistance at [phone].
Para obtener asistencia, póngase en contacto con el servicio de asistencia técnica de
Sekisui Diagnostics al [phone].
RE-ORDER/NUEVOS PEDIDOS
No. 175 OSOM H. Pylori (25 tests)
No. 175 OSOM H. Pylori (25 pruebas)
OSOM
®
is a registered U.S. trademark of Sekisui Diagnostics, LLC.
OSOM
®
es una marca registrada EE.UU. de Sekisui Diagnostics, LLC.
Princeton BioMeditech Corp.
Monmouth Junction, NJ 08852 USA
MANUFACTURED FOR/
FABRICADO POR:
Sekisui Diagnostics, LLC
6659 Top Gun Street
San Diego, CA 92121 USA
Sekisui Diagnostics (UK) Limited
50 Gibson Drive
Kings Hill, West Malling, Kent, ME19 4AF, UK
E C R E P
www.sekisuidiagnostics.com
© 2012 Sekisui Diagnostics, LLC – All rights reserved.